Certara, Inc.

NASDAQ

CERT

Stock

Yield per half year: -19.34%
Dividend yield: 0%
Sector: Healthcare

Compare companies

Download the report:

Excel

Word

PDF

	Certara, Inc.	Gilead Sciences	Amgen
Capitalization
Price	11.18	116.2	306.58
Price priv.
Number of shares, million	160.39	1255	541
Capitalization, billion	2.56	94.55	140.05
EBITDA, billion	0.0724	4.43	13.36
EV, billion	1.84	132.19	189.13
Profit and loss report
Net profit, billion	-0.0121	0.48	4.09
Revenue, billion	0.3851	28.75	33.42
EPS	-0.0751	0.3825	7.56
Balance
Assets, billion	1.58	59	91.84
Debt, billion	0.3119	26.71	60.1
Balance cost, billion	1.06	19.33	5.88
Cash, billion	0.1792	9.99	11.97
Coefficients
Dividend yield, %	0	3.17	2.94
Dividend	0	3.12	9.26
Dividend yield priv., %	0	0	0
Dividend priv.	0	0	0
Dividends/profit, %	0	816.25	118.14
P/S	4.44	4.02	4.22
P/BV	1.61	6	23.99
P/E	171.46	240.57	34.48
Ev/Ebitda	25.44	29.81	14.16
Debt/Ebitda	4.31	6.02	4.5
Efficiency
ROE	-1.14	2.28	67.55
ROA	-0.768	0.7926	4.33
ROIC	-0.2	11.06	17
Ebitda margin	18.79	15.42	39.96
Net margin	-3.13	1.67	12.24
Momentum
1 week, price changes	-4.93 %	+7.31 %	+3.62 %
1 month, price changes	-2.61 %	+3.98 %	+2.8 %
3 months, price changes	+14.9 %	+8.86 %	+12.75 %
6 months, price changes	-19.34 %	+8.08 %	-2.9 %
1 year, price changes	-15.05 %	+30.89 %	-2.89 %
3 years, price changes	-27.59 %	+43.03 %	+15.98 %
5 years, price changes		+77.46 %	+19.95 %
10 years, price changes		+77.16 %	+95.67 %

More data >>

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe